4C Medical is at the top of the list in the top 10 Hottest Medtech start ups for 2018 (with our tissue). I wonder just how much value the market currently places on this agreement?
I have copied the article for you all below for convenience.
There’s a complaint sometimes that innovation is too incremental in the medical device industry. But don’t tell that to the people running the 10 companies included in Medical Design & Outsourcing and MassDevice’s list of the hottest medtech startups of 2018. Our editors came up with a list of 20 interesting young companies. We then surveyed our readers and then whittled the list down to 10. Along the way, we got to see that there are truly game-changing innovations out there — advances that could not only change the treatment of particular diseases but also enable healthcare systems to run more effectively and efficiently. From neuromodulation to treat urinary and bowel dysfunction disorders and type 2 diabetes to new surgical robotics and drug delivery technology, here are
10 of the most exciting medtech startups of 2018.
View attachment 1078963
4C Medical Technologies
Brooklyn Park, Minn.
Founded: 2014
www.4cmed.com Big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott are seeking to move beyond transcatheter aortic valve replacement to the new frontier — transcatheter mitral valve replacement. They’ve
spent hundreds of millions of dollars on companies in the space. 4C Medical Technologies, however, thinks it has a potentially better solution. Instead of replacing a person’s mitral valve, 4C Medical’s AltaValve device is positioned supra-annular to the leaking native mitral, preventing the leak from entering the left atrium. By preserving the native mitral annulus and left ventricle while still treating mitral regurgitation, the AltaValve provides an answer to the complications presently associated with TMVR, according to the company. 4C Medical last year raised $8 million in a round led by Canadian angel network Anges Québec. The AltaValve won first place in the Cardiovascular Research Technologies (CRT) competition held March 3–6, 2018 in Washington, D.C.
–Chris Newmarker, Managing Editor
(20min delay)